Tag Archives: SARS-CoV-2

Introduction Since its appearance in December 2019 in Wuhan (Hubei, China), more than 300 million people worldwide have been infected with the SARS-CoV-2 virus1 (which generates multi-systemic involvement and is an emerging cause of myocardial compromise). This article presents an illustrative case of dilated cardiomyopathy as a complication of viral myocarditis due to SARS-CoV-2. Case presentation Table 1. Most relevant laboratory findings Test Result Reference values Leukocytes 13,400/µL 4,200–10,400/µL Lymphocytes 1,300/µL 300–1,500/µL Haemoglobin 14 g/dL 11.7–15.5 g/dL Platelets 282,000/µL 156,000–373,000/µL